Cargando…
Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53
Mutations in one allele of the TP53 gene in cancer early stages are frequently followed by the loss of the remaining wild-type allele (LOH) during tumor progression. However, the clinical impact of TP53 mutations and p53LOH, especially in the context of genotoxic modalities, remains unclear. Using M...
Autores principales: | Ghaleb, Amr, Yallowitz, Alisha, Marchenko, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881331/ https://www.ncbi.nlm.nih.gov/pubmed/31799437 http://dx.doi.org/10.1038/s42003-019-0669-y |
Ejemplares similares
-
Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells
por: Ghaleb, Amr, et al.
Publicado: (2020) -
p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
por: Alexandrova, Evguenia M, et al.
Publicado: (2017) -
A gain-of-function mutant p53–HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress
por: Li, D, et al.
Publicado: (2014) -
Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells
por: Yallowitz, Alisha, et al.
Publicado: (2018) -
Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas
por: Goto, Akiteru, et al.
Publicado: (1998)